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FAKTOR YANG BERKAITAN DENGAN KANSER PAYUDARA DAN 
PERANAN STATUS PEMAKANAN KE ATAS ADIPONEKTIN BERAT 
MOLEKUL TINGGI SERUM 
 
ABSTRAK 
 
Kanser payudara menjadi pembunuh utama wanita di Malaysia. Status 
pemakanan dan adiponektin adalah faktor risiko yang boleh diubah untuk kejadian 
kanser payudara yang boleh disasarkan dengan cekap. Tujuan kajian ini adalah untuk 
mengenal pasti faktor berkaitan kanser payudara dan perkaitan status pemakanan 
pada adiponektin berat molekul tinggi serum. Kajian ini adalah kajian kes-kontrol 
yang dijalankan dari Januari 2014 hingga Ogos 2015. Kajian ini dijalankan di 
Hospital Universiti Sains Malaysia (HUSM) dan Universiti Sains Malaysia (USM). 
Pesakit yang belum dirawat untuk kanser payudara (n=55) telah diletakkan ke dalam 
kumpulan kes, dan wanita sihat (n=58) yang merupakan kakitangan dari HUSM dan 
USM diletakkan ke dalam kumpulan kawalan. Data sosiodemografi dan reproduktif 
diperolehi melalui soal selidik yang piawai dan data pemakanan diperoleh dari soal 
selidik sejarah pemakanan yang disahkan. Penilaian antropometri (berat badan, 
ketinggian, lilitan pinggang, lilitan pinggul dan komposisi lemak badan) diukur dan 
sampel darah selepas puasa semalaman dianalisis untuk profil lipid, glukosa plasma, 
insulin, sensitiviti tinggi protein reaktif dan adiponektin berat molekul tinggi serum. 
Aktiviti fizikal diukur menggunakan akselerometer selama 2 hari bekerja dan 1 hari 
hujung minggu. Regresi logistik ringkas mendapati faktor-faktor yang dikaitkan 
dengan risiko kanser payudara adalah: sosiodemografi (umur, tahap pendidikan 
rendah, terdedah kepada asap rokok, pendapatan bulanan isi rumah yang rendah), 
 xvii 
 
sejarah kesihatan (tekanan darah sistolik, tekanan darah diastolik, nadi, lebih dari 1 
tahun penggunaan jamu) dan status pemakanan (ukur lilit pinggang, kolesterol HDL, 
trigliserida, glukosa darah dan pengambilan gula). Regresi logistik berganda 
dilakukan untuk menentukan faktor yang berkaitan dengan risiko kanser payudara. 
Faktor yang menyumbang kepada kanser payudara adalah perokok asap sekunder 
(OR = 10.00, [95% CI: 2.42, 41.30]), pendapatan bulanan isi rumah kurang daripada 
RM 2,300 (OR = 18.05, [95% CI: 2.56, 127.10]) dan tekanan darah sistolik (OR = 
1.08, [95% CI: 1.04, 1.12]). Analisis regresi linear berganda menunjukkan terdapat 
hubungan negatif linear yang signifikan antara ukurlilit pinggang dan adiponektin 
berat molekul tinggi serum (β=-0.05; p=0.005) dalam kalangan kes-kes kanser 
payudara. Selain itu, kolesterol HDL secara positif dikaitkan dengan adiponektin 
berat molekul tinggi serum (β=1.83; p=0.010) dalam kalangan kes-kes kanser 
payudara. BMI dikaitkan secara negatif dengan adiponektin berat molekul tinggi 
serum (β=-0.02; p=0.001) dalam kalangan kumpulan kawalan sihat. Kajian ini 
menunjukkan faktor risiko yang boleh diubahsuai berperanan dalam berlakunya 
kanser payudara. 
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FACTORS ASSOCIATED WITH BREAST CANCER AND ROLE OF 
NUTRITIONAL STATUS ON SERUM HIGH-MOLECULAR WEIGHT 
ADIPONECTIN 
ABSTRACT 
 
Breast cancer is the leading killer of women in Malaysia. Nutritional status 
and adiponectin are modifiable risk factors for breast cancer occurrence that can be 
efficiently targeted. The purpose of this study was to determine the associated factor 
of breast cancer and relationship between nutritional status and high molecular 
weight (HMW) adiponectin. This was a case- control study, conducted from January 
2014 until August 2015 at Hospital Universiti Sains Malaysia (HUSM) and 
Universiti Sains Malaysia (USM). Untreated breast cancer cases (n=55) were 
assigned as cases, and healthy controls (n=58) who were staff at HUSM and USM 
acted as controls. Sociodemographic and reproductive data were obtained with a 
standard questionnaire and dietary data was obtained from validated diet history 
questionnaire (DHQ). Anthropometric assessments (weight, height, hip, waist 
circumference (WC) and body fat composition) were measured and overnight fasting 
venous blood samples were analysed for lipid profiles, plasma glucose, insulin, high 
sensitivity C reactive protein (hs-CRP) and HMW adiponectin. Physical activity was 
measured using accelerometer for 2 weekdays and 1 weekend. Simple logistic 
regression found these factors associated with breast cancer risk: sociodemographic 
(age, lower education level, exposed to secondhand smoke, lower monthly household 
income), physical examination (systolic blood pressure, diastolic blood pressure, 
pulse, more than 1 year of traditional medicine) and nutritional status (WC, HDL 
cholesterol, TG, blood glucose and sugar intake). Multiple logistic regression was 
 xix 
 
performed to determine factors associated with breast cancer risk. The predictors of 
breast cancer development were exposed to secondary smoke (OR=10.00, [95% CI: 
2.42, 41.30]), monthly household income of less than RM 2,300 (OR=18.05, [95% 
CI: 2.56, 127.10]) and systolic blood pressure (OR=1.08, [95% CI: 1.04, 1.12]). 
Multiple linear regression analysis revealed that there was a significant linear 
negative relationship between WC and HMW adiponectin (β=-0.05; p=0.005) among 
breast cancer cases. Besides, HDL cholesterol was positively associated with HMW 
adiponectin (β=1.83; p=0.010) among breast cancer cases. BMI was negatively 
associated with HMW adiponectin (β=-0.02; p=0.001) among healthy controls. This 
study indicated the potential role of modifiable risk factor in the occurrence of breast 
cancer. 
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CHAPTER 1 
INTRODUCTION 
 
1.1  Background of the study 
 
Cancer is a name given to a pool of related diseases and can begin in almost any part of 
the human body (National Cancer Institute, 2015b). Cancer cells originated from 
abnormal cells. These cells can keep multiplying without control and invading other 
tissues. Some cancer cells can metastasize to distant sites. Cancer rates are increasing 
globally. Economically-developed countries are estimated to have higher new cases of 
cancer worldwide compared to economically developing countries (International 
Network for Cancer Treatment and Research, 2017).  
 
Malaysia is a developing country with multi-ethnicity groups which has already 
reported to have 11% of principal cause of cancer mortality in women according to all 
medically certified deaths (Al-Naggar et al., 2011). By the year of 2030, the global 
burden is expected by American Cancer Society to grow to 21.4 million new cancer 
cases and 13.2 million cancer deaths. In an effort to ease the global burden of cancer, 
World Health Organization (WHO) and International Agency for Research on Cancer 
(IARC) supports Union for International Cancer Control (UICC) to promote its ways 
through World Cancer Day on 4th February annually (Union for International Cancer 
Control, 2017).  
 
 2 
 
The top 5 cancers affecting Malaysians are breast, colorectal, lung, cervical and 
nasopharyngeal cancer (National Cancer Society Malaysia, 2015). Breast cancer 
became the leading killer of women in Malaysia (25%), other than the Philippines 
(23%), Indonesia (22%), New Caledonia, Vanuatu (both 21%), Singapore (20%) and 
Samoa (13%) (Youlden et al., 2014). It occurs in both men and women although male 
breast cancer is rare. Ductal carcinoma is the most common type of breast cancer which 
begins in the lining of the milk ducts. Other types of breast cancer is lobular carcinoma 
which initiates at the breast milk glands. However, invasive breast cancer has the 
tendency of spreading to surrounding normal tissue from its initial site that is located or 
confined to breast ducts or lobules (National Cancer Institute, 2015a). 
 
A highly heterogeneous disease, breast cancer is a hormone-related disease in 
which the factors modifying the risk are different when breast cancer is diagnosed 
premenopausally or postmenopausally (Becaria Coquet et al., 2016). However, it is 
impossible to identify the exact risk factors that cause the occurrence of breast cancer in 
certain women (Lacey Jr et al., 2009). The survival of breast cancer can be improved 
through early detection which remains the cornerstone of breast cancer control 
(Anderson et al., 2008). Nutritional status, the interplay of anthropometric assessment, 
dietary intake and physical activity are another important factor that may have impact 
on breast cancer risks. Weight gain has been frequently reported in breast cancer 
patients after diagnosis (Yaw et al., 2011). Adherence to poor dietary intakes and 
physical inactivity are the important obesity-related risk factors on influencing breast 
cancer development. This is explained when the most common ways to combat obesity 
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are through nutrition and physical activity (Gershuni et al., 2016). Lifestyle 
modification may perform a multi-targeted therapy to treat breast cancer incidence and 
recurrence as the individual component susceptive in fatality of breast cancer cannot be 
clearly evaluated (Chlebowski, 2013). 
 
Adipokines are proposed to be key mediators in originating many obesity-
associated malignancies (Katira and Tan, 2015). They are produced from stromal cells, 
macrophages and primarily from adipocytes which represent its mechanism through 
endocrine, paracrine and autocrine in the human body (Barone et al., 2016). However, 
among these adipokines, adiponectin is known as multitalented player of innate 
immunity (Luo and Liu, 2016). Adiponectin plays a role in anti-diabetic effect, anti-
inflammatory of atherosclerosis and lipid homeostasis (Liu et al., 2013a). Previous 
epidemiologic studies led to the hypothesis that made adipokine become an inhibitor on 
the proliferation of various cell types by suppressing apoptosis, inhibiting inflammation 
and intensifying cell viability (Wang and Scherer, 2016). Adiponectin was ascertained 
two decades ago when there was a debate between adipose tissue and metabolic 
pathway. Though it has multitalented roles towards many organs, adiponectin played 
two main roles in liver and skeletal muscle by suppressing hepatic gluconeogenesis and 
promoting nutrient utilization (Wang and Scherer, 2016). Adiponectin may also have 
roles in maintenance of metabolic homeostasis and regulation of energy metabolism 
(Ruan and Liu, 2016). Mounting evidence revealed that adiponectin minimizes the risk 
of cancer. 
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1.2  Rationale of the study 
 
Malaysia, one of the developing countries, is experiencing modernization and 
development towards the year of 2020. Given the population boom and aging in 
developing countries, the incidence of breast cancer is increasing sharply due to an 
increase in life expectancy, changes in reproductive factors, increased urbanization and 
adoption of western lifestyles (Shulman et al., 2010). However, breast cancer problem 
was particularly prevalent as the top cancer in women both in the developed and the 
developing world (World Health Organisation, 2017). This increasing phenomenon 
suggests that new exploration is needed for many risks and underlying causes to breast 
cancer.  
 
The contribution of research on various modifiable and non- modifiable risk 
factors established by conclusive research and confirmed by different sources help 
community to be aware at which risk level they are, in developing breast cancer. 
Nutritional status is suggested as one of the modifiable risk factors for breast cancer 
occurrence (Nomura et al., 2016). The occurrence of breast cancer is stoppable if the 
modifiable risk factors can be overcome starting from adult life (Tamimi et al., 2016).  
Factors that may affect the risk of cancer include dietary, physical activity, obesity, 
alcohol and environmental risk factor (National Cancer Institute, 2012). From this 
perspective, highlighting the nutritional status of women is therefore relevant to assist in 
predicting, declining and avoiding future breast cancer occurrence. 
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A study from Shahar (2010) had been conducted at Klang Valley (West 
Peninsular Malaysia) among newly-diagnosed breast cancer had similar study design. It 
is different from this study which has been conducted in Kelantan (East Peninsular 
Malaysia) that may have influence in lifestyle due to different culture and 
socioeconomic factors between west and east Malaysia. Furthermore, most studies on 
physical activity level amog breast cancer frequently focused on cancer survivors rather 
than untreated breast cancer patients. The findings on physical activity level using 
accelerometer were lacking among Malaysian untreated breast cancer women. 
 
Circulating adiponectin level has been examined by many studies through meta- 
analysis as one of the associated risk factors of breast cancer (Ye et al., 2014). 
However, it is currently an unknown mechanism on how adiponectin modulates breast 
cancer. Exploring the causal and functions of adiponectin may suggest a novel approach 
for breast cancer prevention. Yet, little is known about the adiponectin level among 
Malaysian untreated breast cancer women. Therefore, a study needs to be established to 
provide associated risk factors of breast cancer and impact of nutritional status on 
adiponectin among breast cancer cases and healthy controls. 
 
1.3  Significance of the study 
 
This study provides an updated data of health status between breast cancer cases and 
healthy controls. Discursive parameters related to the risk factors of breast cancer 
occurrence were analysed throughout the study including health status, dietary intake, 
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anthropometry measurement, body composition assessment and physical activity level. 
Besides, biochemical profiles of breast cancer and healthy controls were examined such 
as glucose, lipid profiles, C-reactive profiles, insulin and adiponectin. All these data add 
valuable information to the literature of breast cancer in Malaysia. Efforts in 
understanding and improving nutritional status may provide greater information on 
underlying mechanism that modulates breast cancer. 
 
In future, the adiponectin biomarkers could be used by clinicians as a routine 
clinical practice to screen patients due to its therapeutic reactivation of anti-neoplastic 
signaling adiponectin (Surmacz, 2013). The study also can stimulate more research 
inspirations especially in the aspect of intervention study towards breast cancer 
survivors.  The comparison data discovered through this case- control study is important 
to elucidate the potential causative factors of breast cancer in order to create guidelines 
of breast cancer prevention among Malaysian women. The exploration of potential risk 
of breast cancer would expand the knowledge associated to the mechanism modulated 
to breast cancer. The present findings would therefore provide conclusive evident and 
help health professionals generate approaches to lessen the health burdens of breast 
cancer among Malaysian women. 
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1.4  Objectives 
 
 General Objective 
 
To determine the associated factor of breast cancer and role of nutritional status on high 
molecular weight (HMW) adiponectin. 
 
 Specific Objectives 
 
i. To determine sociodemographic factors among breast cancer patients and 
healthy controls 
ii. To determine physical examination and reproductive factors among breast 
cancer patients and healthy controls 
iii. To determine nutritional status factors among breast cancer patients and 
healthy controls 
iv. To determine the associated factors (sociodemographic, physical 
examination, reproductive and nutritional status) of breast cancer 
v. To investigate the association between nutritional status and HMW 
adiponectin among breast cancer patients 
vi. To investigate the association between nutritional status and HMW 
adiponectin among healthy controls 
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1.5  Research questions 
 
i. Is there any association of the sociodemographic factors between breast cancer 
patients and healthy controls? 
ii. Is there any association of the physical examination and reproductive factors 
between breast cancer patients and healthy controls? 
iii. Is there any association of the nutritional status factors between breast cancer 
patients and healthy controls? 
iv. Is there any factors associated with the breast cancer? 
v. Is there any association between nutritional status and HMW adiponectin among 
breast cancer patients? 
vi. Is there any association between nutritional status and HMW adiponectin among 
healthy controls? 
 
1.6  Null hypotheses 
 
i. There is no association of the sociodemographic factors between breast cancer 
patients and healthy controls 
ii. There is no association of the physical examination and reproductive factors 
between breast cancer patients and healthy controls 
iii. There is no association of the nutritional status factors between breast cancer 
patients and healthy controls 
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iv. There are no associated factors with the breast cancer in sociodemographic, 
physical examination, reproductive and nutritional status 
v. There is no association between nutritional status and HMW adiponectin among 
breast cancer patients. 
vi. There is no association between nutritional status and HMW adiponectin among 
healthy controls. 
 
1.7  Conceptual framework  
 
The conceptual framework of the study is presented in Figure 1.1. Two types of breast 
cancer risk consist of modifiable (sociodemography, reproductive and nutritional status) 
and non-modifiable risk factors (genetic make-up and reproductive). Modifiable risk 
factor is a type of risk that can be overcome through lifestyle changes while non-
modifiable risk factor cannot be modified because it is not under one’s control. An 
example for modifiable reproductive risk factor is breastfeeding practice and non-
modifiable reproductive risk is age at menarche. Nutritional status interplay of 
anthropometry, biochemical marker, dietary intake and physical activity. Abnormal 
anthropometric measurement, unhealthy intake and physical inactivity as well as 
abnormal metabolic status contribute to higher risk of getting overweight and obesity. 
Moreover, anthropometric factors, dietary intakes also have relationship with 
adiponectin level. Obesity is one of the unhealthy lifestyle that may induce low 
adiponectin level (hypoadiponectinemia). Thus, low adiponectin level has an 
association with higher breast cancer risk. 
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Figure 1.1 Conceptual framework of the study 
(Adopted from Shahar et al., 2010; James et al., 2015; Tamimi et al., 2016; current 
study) 
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CHAPTER 2  
LITERATURE REVIEW 
 
2.1 Breast cancer 
 
Breast cancer is a type of disease in which tumor is formed from aggressive cells in the 
breast. Breast cancer origins may come from various parts of the breast. The most 
common are ductal and lobular cancer while other types of breast cancer are less 
common (American Cancer Society, 2017a). Up to 21 distinct histologic subtypes and 
at least 4 different molecular subtypes of breast cancer discovered (DeSantis et al., 
2016). Pathology report will confirm whether the breast cancer is a type of in situ or 
invasive. In situ breast cancers usually consists of ductal carcinoma in situ and lobular 
carcinoma in situ (confined within the ducts or lobules of the breast). Invasive breast 
cancer usually originated from the breast ducts or lobules which then infiltrate glandular 
walls or ducts to the nearest breast tissue (American Cancer Society, 2009). 
 
Hormone receptor assay from pathology report provides result whether or not 
the breast cancer cells have receptors for the endocrine hormones. Estrogen receptor 
positive (ER+) and progesterone receptor positive (PR+) receive estrogen and 
progesterone signals to promote the breast cancer cells growth (Breast cancer.org, 
2017). In addition, there is also an aggressive growing cancer due to high production of 
a protein known as human epidermal growth factor receptor 2 (HER2) (American 
Cancer Society, 2016a). Breast cancer patients may have the combination of these three 
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receptors called as triple positive breast cancer while triple negative breast cancer are 
not positive for estrogen, progesterone receptors, and HER2 (National Breast Cancer 
Foundation, 2016). 
 
2.2 Prevalence of breast cancer 
 
Breast cancer is one of the vital reproductive health problems among women 
(Forouzanfar et al., 2011). Breast cancer is the most popular diagnosed cancer in 
women in which the cases are higher in less developed regions. Besides, it is the second 
most common cancer worldwide and being in the fifth ranks for the cause of death 
(Ferlay et al., 2015). Women who underwent breast screening are prone to be diagnosed 
earlier with breast cancer than women who did not experience the screening. This 
approach may help one in eight women to be diagnosed earlier, spare the need for a 
mastectomy and avoid from breast cancer mortality (Screening, 2016). 
 
Women at a younger age dying from breast cancer are rising in most countries 
especially in the developing world (Forouzanfar et al., 2011) and it is a leading cause of 
death and disability among women in low- and middle-income countries (Porter, 2008). 
According to National Cancer Registry (NCR) 2011, breast cancer is the commonest 
cancer among females in Malaysia. Several Asian countries were reported to have rapid 
increase in breast cancer mortality rates particularly Malaysia (Youlden et al., 2014). 
Despite a number of embattled therapies have been implemented in treating breast 
cancer, the breast cancer incidence and mortality rates remain on the rise, globally. 
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Breast cancer incidence were reported to increase by 3.1% yearly from 1980 to 2010 
(Chong et al., 2016).  
 
 
Figure 2.1 An estimated global numbers of new cases (thousands) with 
proportions for more developed and less developed regions 
(Source: Ferlay et al., 2015) 
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2.3 Nutritional status 
 
Nutritional status is an essential predictor of clinical outcome such as malnutrition. 
Impaired nutritional status was linked with inadequate food intake, unsustained hunger 
and metabolic inefficiency (Shakersain et al., 2016). Several study modulated 
nutritional status as the assessment of anthropometry and body composition such as 
body mass index and body fat distribution (Bechard et al., 2016). In contrast, nutritional 
status also has been defined in the scope of dietary intake by considering food intakes 
and utilisation of nutrients were affecting the consumer‘s health condition (Jeejeebhoy 
et al., 1990). 
 
Two main modifiable risk factors in prevention of cancer were body weight and 
dietary intake (American Cancer Society, 2016b). But then, the American Cancer 
Society provided new nutritional guidelines for the prevention of cancer by grouping 
the recommendations into categories of weight management, physical activity and 
dietary intake (Bail et al., 2016). This recommendation may be used as nutritional 
education in promoting good health and optimum nutritional status among public. 
Moreover, nutritional status is one of the greatest concern towards the effort to increase 
patient’s quality of life. For example, Subjective Global Assessment (SGA) form has 
been utilized to screen patients with malnutrition in HUSM. This nutritional assessment 
tool may help beforehand in nutritional intervention to overcome disease complication 
(Sahran et al., 2016). 
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2.4 Adipokines 
 
Adipose tissue is a complex endocrine organ with convoluted role in homeostasis 
(Booth et al., 2016). It can be epitomised up to 50% of the body weight (Peurichard et 
al., 2017) and classified into white adipose tissue and brown adipose tissue (Hussein et 
al., 2017). 
 
White adipose tissue is one of the most abundant tissues in human in which 
abdominal subcutaneous adipose tissue and visceral adipose tissue are the main 
adipocyte depots of white adipose tissue (Bj et al., 2011). On the other hand, additional 
white adipose tissue are distributed at disparate organs such as lung, heart, and kidney. 
White adipose tissue is designed from various type of cells including adipocytes, 
lymphocytes, endothelial cells, macrophages and fibroblasts (Kwon and Pessin, 2013). 
Its primary role is to store excess energy in the form of fat which then been utilised 
during energy deprivation and act as endocrine organ (Gesta and Kahn, 2017).  
  
Brown adipose tissue exists abundantly in new born and hibernating mammals 
but almost absent in human adults (Coelho et al., 2013). It is located in cervical-
supraclavicular regions and contained higher number of mitochondria and capillaries. 
This enables brown adipose tissue to generate heat and dissipate energy (Ravussin and 
Galgani, 2011) through its mitochondria when the proton motive force across the inner 
membrane is unrestrained as heat rather than converted to ATP (Klingenspor et al., 
2017). Recent interest of studies on finding obesity solution suggested on the 
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conversion of fat accumulating white adipose tissue into energy-dissipating brown 
adipose tissue may be a potential harmless therapy to overcome obesity epidemic 
(Montanari et al., 2017). 
 
Subcutaneous or visceral adipose tissue (white adipose tissue) are responsible 
for the secretion of various factors known as adipokines, which can act locally or 
distally on other tissues (Kwon and Pessin, 2013). Adipokines are protein mediators 
secreted by adipose tissue (Leivo-Korpela et al., 2011) and many grand new adipokines 
were discovered recently like adiponectin, leptin, and vaspin (Liu et al., 2013). Adipose 
tissue has a role of multifunctional secretory organ which act to control energy 
homoeostasis through peripheral and central regulation as well as plays an important 
role in innate immunity (Piya et al., 2013). Besides adipocyte, adipose tissue 
macrophages also become the main producers of adipokines (Capel et al., 2009).  
 
Adipokines can act centrally to regulate appetite and energy expenditure, and 
peripherally affect insulin sensitivity, oxidative capacity and lipid uptake (de Oliveira Leal 
and Mafra, 2013). At this point, adipokines are categorized as pro- and anti-inflammatory 
adipokines according to their effects on inflammatory responses in adipose tissues (Kwon 
and Pessin, 2013). Adipokines may have implicated through neuroendocrine, autonomic, 
or immune pathways in human body (Li et al., 2013). Figure 2.1 shows adipose tissue 
plays endocrine role between organs. Adiponectin encourages insulin sensitivity in 
skeletal muscle and gives beneficial effects on cardiovascular and b-cell function of 
pancreas.   
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Figure 2.2 Positive regulation on multiple organs by adiponectin 
(Source: Romacho et al., 2014)  
 
2.4.1 Adiponectin 
 
Adiponectin, an adipocyte-derived adipokine was discovered over the past 20 years. 
Adiponectin (formerly named as adipocyte complement-related protein of 30 kDa, 
Acrp30) was revealed in 1995 from a subtractive complementary deoxyribonucleic acid 
(cDNA) library enriched in rodent adipocyte-specific genes (Scherer et al., 1995). Then, 
in 1996, cDNA library from human adipose tissue was designed by Maeda et al., 
(1996), also found adiponectin (named it adipose most abundant gene transcript 1 
(apM1) and it is encoded by the ADIPOQ gene (Goto et al., 2017). The human 
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adiponectin gene located on chromosome 3q26, an area associated with type 2 diabetes 
mellitus and metabolic syndrome susceptibility (Al Khaldi et al., 2015). 
 
2.4.1 (a)  Structure and circulating levels 
 
Nakano (1996) discovered circulating adiponectin when isolated from human plasma 
via gelatin-based affinity chromatography, high salt elution and protein sequencing. 
Full-length adiponectin comprises 244 amino acid, polypeptide, a collagen like domain 
at N-terminal secretory sequence, and a C-terminal globular domain with structural 
similarities to the complement factor C1q (Xu et al., 2015). The adiponectin structure 
presented an asymmetric trimer of three identical monomers (Wang and Scherer, 2016). 
Post-translational modifications including hydroxylation and glycosylation were needed 
by full-length adiponectin to perform its role.  
 
Adiponectin exists as multiple complexes with different molecular weights. The 
adiponectin molecules are circulated from adipocytes as trimers (~90 kDa; the basic 
unit); low molecular weight (LMW), hexamers (~180 kDa) and high molecular weight 
(HMW) isoforms (12–18-mer; >400 kDa) (Wang et al., 2017). Figure 2.2 shows the 
structure of adiponectin consisted of three distinct complex forms, HMW (12–18mer), 
MMW (hexamer) and LMW (trimer). Matsuzawa (2010) reported that the average 
concentrations of adiponectin in human plasma are extremely high up to 5-10 μg/ml. 
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Figure 2.2 Structure of adiponectin 
(Source: Wang and Scherer, 2016) 
 
2.4.1 (b)  Receptors 
 
Adiponectin receptor 1 (AdipoR1) and adiponectin receptor 2 (AdipoR2) are two 
transmembranous adiponectin receptor which contribute to biological effects of 
adiponectin such as inducing the activation of protein kinases, mainly monophosphate-
activated protein (AMP) kinase and mitogen-activated protein (MAP) kinase 
(Yamauchi et al., 2003). Besides that, AdipoR1 and AdipoR2 play roles in inhibition of 
breast cancer cells proliferation and induction of apoptosis (Dieudonne et al., 2006). 
This has been strengthen with another study that resulted in AdipoR1 and AdipoR2 
directly amend the growth of normal breast epithelial cells and breast cancer cells after 
determine the expression of AdipoR1 and AdipoR2 in the human breast epithelial cells 
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and breast cancer cells (Takahata et al., 2007). Obesity will reduce adiponectin 
sensitivity due to reduction of adiponectin expression levels of AdipoR1 or AdipoR2, 
which finally leads to insulin resistance (Kadowaki and Yamauchi, 2005). 
 
2.4.1 (c) Clinical features 
 
Adiponectin found to be the most abundant transcript in visceral adipose tissue in the 
form of collagen-like protein that had bioactive substances. It plays multiple roles 
including anti-diabetic, anti-hypertensive, anti-inflammatory, anti-atherogenic 
properties and anti-oncogenic function (Matsuzawa, 2010). Silha et al. (2003) reported 
that decreased plasma adiponectin levels are found in obese compared with lean 
subjects. Adiponectin shown to demonstrate features of regulation lipid and glucose 
metabolism, growth of insulin sensitivity and protection against chronic inflammation 
(Liu and Liu, 2010). Thus, hypoadiponectinemia is associated with insulin resistance, 
hyperinsulinemia and the possibility of developing type 2 diabetes mellitus (Kaur, 
2014). 
 
The increasing percentage of obesity in the population has independent impact 
on cancer progression when previous study showed that fat tissue-derived adipokines, 
adiponectin has been involved in mammary carcinogenesis (VanSaun, 2013). It was 
found that adiponectin is the most abundant adipokine secreted by white adipose tissue 
(Xu et al., 2016). It may limit tumorgenesis primarily by inhibiting cell metabolism and 
resisting detrimental leptin effects in breast cancer models (Surmacz, 2013). HMW 
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adiponectin is proposed to be the best predictor of metabolic parameters than total 
adiponectin. (Misra et al., 2017) and is the only form that decreases after a glucose load, 
propounding that HMW adiponectin form is affected more rapidly than LMW or MMW 
form (Ozeki et al., 2009). 
 
Since adiponectin can be a suitable indicator of metabolic status, a study 
suggested developing adiponectin biomarkers in the clinic in similar ways as C-reactive 
protein. Clinically practice, high-sensitivity C-reactive protein (hs-CRP) was tested to 
predict cardiovascular risk which showed that both biomarkers had similar systemic 
readouts. Adiponectin biomarker may serve as a more stable metabolic dysfunction 
indicator as it is less prone to acute inflammator challenges than CRP (Kusminski and 
Scherer, 2009). Breast cancer patients also may benefit from adiponectin biomarkers 
due to its therapeutic reactivation of anti-neoplastic signaling adiponectin (Surmacz, 
2013). 
 
The association between adiponectin and obesity with breast cancer risk is well 
established discovery that culminate to speculation of adiponectin plays a role in breast 
cancer development. The first study in 2003 by Miyoshi et al reported the data of low 
serum adiponection levels are significantly associated with high risk of breast cancer. 
Furthermore, a case-control study conducted in Malaysia on roles of adiponectin in 
occurrence of breast cancer shows that low serum adiponectin was associated with 
breast cancer risk among subjects (Shahar et al., 2010). However, another recent case- 
control study shows significantly higher of adiponectin level in newly diagnosed breast 
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cancer patients compared to controls, suggesting that this outcome may be due to the 
hypothesis that breast tissue can produce adiponectin (Al Awadhi et al., 2012). 
 
The first team conducted a case–control study determining the connection 
between adiponectin levels and breast cancer risk was Miyoshi et al. 2003. They 
acclaimed low level of serum adiponectin levels in breast cancer patients (7.57 µg/ml) 
compared to controls (8.83 µg/ml). According to meta-analysis, six studies were 
conducted in Asia while two from Europe. Results from these observational studies 
suggested that breast cancer cases had lower adiponectin level (95% CI:-0.618, -0.161; 
p value= 0.001) than controls (Ye et al., 2014). According to systematic review and 
meta-analysis from 10 studies on dose-response analysis showed that an increase of 3 
mg/ml of adiponectin corresponded to a 5% breast cancer risk reduction (Macis et al., 
2014). 
 
Moreover, mean of HMW adiponectin level among Japanese women were 
reported significantly lower in breast cancer cases compared to controls in regard to 
menopausal status. In premenopausal women, the mean HMW adiponectin 
concentration was 4.2 µg/ml among cases and 7.6 µg/ml among controls while in 
postmenopausal women, it was 5.2 µg/ml and 9.2 µg/ml among cases and controls 
(Minatoya et al., 2014). Assiri et al. 2015, reported that adiponectin was a risk factor for 
breast cancer in both premenopausal and postmenopausal women. More than that, the 
risk of breast cancer among postmenopausal women were increased in those with obese 
problem (Chen et al., 2006).  
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2.5 Predictor factors associated with the occurrence of breast cancer 
 
Research into the causes of breast cancer has progressed to the point of risk markers to 
distinguish between women at different levels of risk which resulting into modifiable 
and non-modifiable risk factors. Non- modifiable risk factors of breast cancer consist of 
age, family history, age at first full-term pregnancy, early menarche, late menopause, 
and breast density. Other factors associated with increased breast cancer risk are 
modifiable such as physical inactivity, alcohol consumption and postmenopausal 
obesity (American Cancer Society, 2017b).  
 
Based on the breast cancer health disparities study, both modifiable and non-
modifiable risk factors are inter-related. Dietary factors had relationship with 
angiogenesis-related genes which led to breast cancer carcinogenesis (Slattery et al., 
2014). Moreover, modifiable factors also had effect on specific breast cancer subtype. 
Poor prognostic triple negative tumors may be prevented through balanced healthy 
weight while extended breastfeeding period and higher parity may minimize luminal 
breast cancer (Turkoz et al., 2013).  
 
Risk factors of  breast cancer occurrence are divided into 3 major categories 
which are genetic, reproductive and environmental factors (Ban and Godellas, 2014). 
This study specifically divides risk factors into modifiable and non-modifiable factor. 
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Focus was given to genetic risk (non-modifiable), nutritional risk (modifiable) and 
reproductive (modifiable and non-modifiable). 
 
2.5.1 Genetic risk of breast cancer 
 
The risk of breast cancer at different levels may be identified through data bank of 
multiple common susceptibility alleles for cancer of breast (Mavaddat et al., 2015). The 
most famous susceptibility genes of breast cancer being studied for breast cancer are 
BRCA1 and BRCA2 (BReast CAncer). Both BRCA1 and BRCA2 are initially been 
transcripted to prevent from cancer occurrence but any mutation occurred in any 
BRCA1 and BRCA2 or both may lead those carrier to breast cancer exposure (Centers 
for Disease Control and Prevention, 2014). About 45 to 80% lifetime risk among 
women carrying BRCA1 or BRCA2 gene mutation risky to get breast cancer (Geyer et 
al., 2017). Most of the BRCA1 allied with triple negative breast cancer while BRCA2 
cancers associated with ER+ (Macedo et al., 2016). 
 
A genetic testing study of 60,000 female patients with breast cancer was 
conducted via hereditary cancer gene panels to determine germline cancer predisposing 
mutations. As a result, 9% of women were detected with mutations in which moderate 
risk (RR>2.0) of breast cancer association with ATM, RAD51D, NF1, and MSH6 and 
high risk (RR>5.0) association with genes BRCA1, BRCA2, PALB2 (Couch et al., 
2017). This large genetic testing study contributed in providing functional data in 
hereditary cancer gene panels and accumulated risk estimates for many predisposition 
